Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. (Q45997794)
Jump to navigation
Jump to search
scientific article published on 23 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. |
scientific article published on 23 May 2009 |
Statements
1 reference
Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. (English)
1 reference
Mohamed A Ibrahim
1 reference
Osama M Ashour
1 reference
Yasmin F Ibrahim
1 reference
Hussian I El-Bitar
1 reference
Wafaey Gomaa
1 reference
Salama R Abdel-Rahim
1 reference
23 May 2009
1 reference
60
1 reference
5
1 reference
373-381
1 reference
Identifiers
1 reference